The women's health initiative: Lessons learned

Annual Review of Public Health

Volumn 29, Issue , 2008, Pages 131-150

  Prentice, Ross L ^a   Anderson, Garnet L ^a  

^a USA   (United States)

Author keywords

Calcium vitamin D; Dietary fat; Disease prevention; Postmenopausal hormones; Randomized controlled trial; Specimen repository

Indexed keywords

CALCIUM; COLECALCIFEROL; CONJUGATED ESTROGEN; MEDROXYPROGESTERONE ACETATE;

BREAST CANCER; CALCIUM ABSORPTION; CANCER PREVENTION; CLINICAL PRACTICE; CLINICAL TRIAL; COHORT ANALYSIS; COLORECTAL CANCER; CONFERENCE PAPER; FAT INTAKE; HEALTH CARE UTILIZATION; HEALTH PROGRAM; HEALTH STATUS; HIP FRACTURE; HUMAN; INTERVENTION STUDY; ISCHEMIC HEART DISEASE; LEARNING; LOW FAT DIET; MEDICAL EDUCATION; MEDICAL INFORMATION; MEDICAL RESEARCH; MENOPAUSAL SYNDROME; OBSERVATIONAL STUDY; OSTEOLYSIS; PATIENT MONITORING; PRIORITY JOURNAL; PROPHYLAXIS; QUALITY CONTROL; RISK FACTOR; TREATMENT OUTCOME; VITAMIN SUPPLEMENTATION;

AGED; BREAST NEOPLASMS; CALCIUM, DIETARY; COLORECTAL NEOPLASMS; CORONARY DISEASE; DIET, FAT-RESTRICTED; ESTROGEN REPLACEMENT THERAPY; FEMALE; HIP FRACTURES; HUMANS; MIDDLE AGED; POSTMENOPAUSE; PRIMARY PREVENTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; UNITED STATES; VITAMIN D; WOMEN'S HEALTH;

EID: 42949166734     PISSN: 01637525     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.publhealth.29.020907.090947     Document Type: Conference Paper

References (74)

1. Anderson GL, Judd HL, Kaunitz AM, Barad DH, Beresford SA, et al. 2003. Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial. JAMA 290:1739-48
2. Anderson GL, Kooperberg C, Geller N, Rossouw JE, Pettinger M, Prentice RL. 2007. Monitoring and reporting of the Women's Health Initiative randomized hormone therapy trials. Clin. Trials 4:207-17
3. Armstrong B, Doll R. 1975. Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int. J. Cancer 15:617-31
4. Barrett-Connor E, Grady D. 1998. Hormone replacement therapy, heart disease and other considerations. Annu. Rev. Public Health 19:55-72
5. Barrett-Connor E, Grady D, Stefanick ML. 2005. The rise and fall of menopausal hormone therapy. Annu. Rev. Public Health 26:115-41
6. Beresford SA, Johnson KC, Ritenbaugh C, Lasser NL, Snetselaar LG, et al. 2006. Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative randomized controlled Dietary Modification trial. JAMA 295:643-54
7. Bingham SA. 2003. Urine nitrogen as a biomarker for the validation of dietary protein intake. J. Nutr. 133:9215-45
8. Bingham SA, Luben R, Welch A, Wareham N, Khaw KT, Day N. 2003. Are imprecise methods obscuring a relation between fat and breast cancer? Lancet 362:212-14
9. Bonds DE, Lasser N, Qi L, Brzyski R, Caan B, et al. 2006. The effect of conjugated equine oestrogen on diabetes incidence: the Women's Health Initiative randomised trial. Diabetologia 49:459-68
10. Bowen D, Clifford CK, Coates R, Evans M, Feng Z, et al. 1996. The Women's Health Trial: feasibility study in minority populations. Design and baseline descriptions. Ann. Epidemiol. 6:507-19
11. Brunner RL, Gass M, Aragaki A, Hays J, Granek I, et al. 2005. Effects of conjugated equine estrogen on health-related quality of life in postmenopausal women with hysterectomy: results from the Women's Health Initiative randomized clinical trial. Arch. Intern. Med. 165:1976-86
12. Bush TL, Barrett-Connor E, Cowan LD, Criqui MH, Wallace RB, et al. 1987. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation 75:1102-9
13. Cauley JA, Robbins J, Chen Z, Cummings SR, Jackson RD, et al. 2003. Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial. JAMA 290:1729-38
14. Chapuy MC, Arlot ME, Duboeuf F, Brun J, Crouzet B, et al. 1992. Vitamin D3 and calcium to prevent hip fractures in elderly women. N. Engl. J. Med. 327:1637-42
15. Chlebowski RT, Hendrix SL, Langer RD, Stefanick ML, Gass M, et al. 2003. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative randomized trial. JAMA 289:3243-53
16. Chlebowski RT, Wactawski-Wende J, Ritenbaugh C, Hubbell FA, Ascensao J, et al. 2004. Estrogen plus progestin and colorectal cancer in postmenopausal women. N. Engl. J. Med. 350:991-1004
17. Cirillo DJ, Wallace RB, Rodabough RJ, Greenland P, LaCroix AZ, et al. 2005. Effect of estrogen therapy on gallbladder disease. JAMA 293:330-39
18. Cochrane B, Lund B, Anderson S, Prentice RL. 2003. The Women's Health Initiative: aspects of management and coordination. In Diversity in Health Care Research: Strategies for Multisite, Multidisciplinary and Multiethnic Projects, ed. JW Hawkins, LA Haggerty, pp. 181-207. New York: Springer
19. Cummings RG. 1990. Calcium intake and bone mass: a quantitative review of the evidence. Calcifi Tissue Int. 47:194-201
20. Curb JD, Prentice RL, Bray PF, Langer RD, Van Horn L, et al. 2006. Venous thrombosis and conjugated equine estrogen in women without a uterus. Arch. Intern. Med. 166:772-80
21. Cushman M, Kuller LH, Prentice R, Rodabough RJ, Psaty BM, et al. 2004. Estrogen plus progestin and risk of venous thrombosis. JAMA 292:1573-80
22. Dawson-Hughes B. 1991. Calcium supplementation and bone loss: a review of controlled clinical trials. Am. J. Clin. Nutr. 54:2745-805
23. Day NE, McKeown N, Wong MY, Welch A, Bingham S. 2001. Epidemiologic assessment of diet: a comparison of a 7-day diary with a food frequency questionnaire using urinary markers of nitrogen, potassium and sodium. Int. J. Epidemiol. 30:309-17
24. Freedman LS, Clifford C, Messina M. 1990. Analysis of dietary fat, calories, body weight and the development of mammary tumors in rats and mice: a review. Cancer Res. 50:5710-19
25. Freedman LS, Potischman N, Kipnis V, Midthune D, Schatzkin A, et al. 2006. A comparison of two dietary instruments for evaluating the fat-breast cancer relationship. Int. J. Epidemiol. 35:1011-21
26. Garland CF, Comstock GW, Garland FC, Helsing KJ, Shaw EK, Gorham ED. 1989. Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet 2:1176-78
27. Grady D, Herrington D, Bittner V, Blumenthal R, Davidson M, et al. 2002. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA 288:49-57
28. Grady D, Rubin SM, Pettiti DB, Fox CS, Black D, et al. 1992. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann. Intern. Med. 117:1016-36
29. Hays J, Ockene JK, Brunner RL, Kotchen JM, Manson JE, et al. 2003. Effects of estrogen plus progestin on health-related quality of life. N. Engl. J. Med. 348:1839-54
30. Heitmann BL, Lissner L. 1995. Dietary underreporting by obese individuals: Is it specific or nonspecific? BMJ 311:986-89
31. Hendrix SL, Cochrane BB, Nygaard IE, Handa VL, Barnabei VM, et al. 2005. Effects of estrogen with and without progestin on urinary incontinence. JAMA 293:935-48
32. Hendrix SL, Wassertheil-Smoller S, Johnson KC, Howard BV, Kooperberg C, et al. 2006. Effects of conjugated equine estrogen on stroke in the Women's Health Initiative. Circulation 113:2425-34
33. Hersh AL, Stefanick M, Stafford RS. 2004. National use of postmenopausal hormone therapy. JAMA 291:47-53
34. Howard BV, Van Horn L, Hsia J, Manson JE, Stefanick ML, et al. 2006. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative randomized controlled Dietary Modification trial. JAMA 295:655-66
35. Howe GR, Aronson KJ, Benito E, Castelleto R, Cornee J, et al. 1997. The relationship between dietary fat intake and risk of colorectal cancer: evidence from the combined analysis of 13 case-control studies. Cancer Causes Control 8:215-28
36. Howe GR, Hirohata T, Hislop TG, Iscovich JM, Yuan JM, et al. 1990. Dietary factors and risk of breast cancer: combined analysis of 12 case-control studies. J. Natl. Cancer Inst. 82:561-69
37. Hsia J, Criqui MH, Herrington DM, Manson JE, Wu L, et al. 2006. Conjugated equine estrogens and peripheral arterial disease risk: the Women's Health Initiative. Am. Heart J. 152:170-76
38. Hsia J, Criqui MH, Rodabough RJ, Langer RD, Resnick HE, et al. 2004. Estrogen plus progestin and the risk of peripheral arterial disease: the Women's Health Initiative. Circulation 109:620-26
39. Hsia J, Langer RD, Manson JE, Kuller L, Johnson KC, et al. 2006. Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative. Arch. Intern. Med. 166:357-65
40. Hulley S, Furberg C, Barrett-Connor E, Cauley J, Grady D, etal. 2002. Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/Progestin Replacement Study Follow-up (HERS II). JAMA 288:58-64
41. Hulley S, Grady D, Bush T, Furberg C, Herrington D, et al. 1998. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 280:605-13
42. Insull W, Henderson MM, Prentice RL, Thompson DJ, Clifford C, et al. 1990. Results of a randomized feasibility study of a low-fat diet. Arch. Intern. Med. 150:421-27
43. Jackson RD, LaCroix AZ, Gass M, Wallace RB, Robbins J, et al. 2006. Calcium plus Vitamin D supplementation and the risk of fractures. N. Engl. J. Med. 354:669-83
44. Jackson RD, Wactawski-Wende J, LaCroix AZ, Pettinger M, Yood RA, et al. 2006. Effects of conjugated equine estrogen on risk of fractures and BMD in postmenopausal women with hysterectomy: results from the Women's Health Initiative randomized trial. J. Bone Miner. Res. 21:817-28
45. Manson JE, Hsia J, Johnson KC, Rossouw JE, Assaf AR, et al. 2003. Estrogen plus progestin and the risk of coronary heart disease. N. Engl. J. Med. 349:523-34
46. Margolis KL, Bonds DE, Rodabough RJ, Tinker L, Phillips LS, et al. 2004. Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women's Health Initiative Hormone Trial. Diabetologia 47:1175-87
47. Million Women Study Collab. 2003. Breast cancer and hormone replacement therapy in the Million Women Study. Lancet 362:419-27
48. PEPI Trial Writ. Group. 1995. Effects of estrogen or estrogen/progestin regimes on heart disease risk factors in postmenopausal women: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA 273:199-208
49. PEPI Trial Writ. Group. 1996. Effects of hormone replacement therapy on endometrial histology in postmenopausal women: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA 275:370-75
50. PEPI Trial Writ. Group. 1996. Effects of hormone therapy on bone mineral density: results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA 276:1389-96
51. Prentice RL, Caan B, Chlebowski RT, Patterson R, Kuller LH, et al. 2006. Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative randomized controlled Dietary Modification trial. JAMA 295:629-42
52. Prentice RL, Langer R, Stefanick M, Howard B, Pettinger M, et al. 2005. Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between Women's Health Initiative Clinical Trial and Observational Study Results. Am. J. Epidemiol. 162:404-14
53. Prentice RL, Langer R, Stefanick ML, Howard BV, Pettinger M, et al. 2006. Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease. Am. J. Epidemiol. 163:589-99
54. Prentice RL, Sheppard L. 1990. Dietary fat and cancer: consistency of the epidemiologic data and disease prevention that may follow from a practical reduction in fat consumption. Cancer Causes Control 1:81-97
55. Prentice RL, Thompson DJ, Clifford C, Gorbach S, Goldin B, Byar D. 1990. Dietary fat reduction and plasma estradiol concentration among healthy postmenopausal women. J. Natl. Cancer Inst. 82:129-34
56. Rossouw JE, Anderson GL, Oberman A. 2003. Women's Health Initiative: baseline monograph - foreword. Ann. Epidemiol. 13:S1-4
57. Rossouw JE, Finnegan LP, Harlan WR, Pinn VW, Clifford C, McGowan JA. 1995. The evolution of the Women's Health Initiative: perspectives from the NIH. J. Am. Med. Womens Assoc. 50:50-55
58. Rossouw JE, Prentice RL, Manson JE, Wu L, Barad D, et al. 2007. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 297:1465-77
59. Schoeller DA. 1999. Recent advances from application of doubly labeled water to measurement of human energy expenditure. J. Nutr. 192:1765-68
60. Shumaker SA, Legault C, Kuller L, Rapp SR, Thal L, et al. 2004. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA 291:2947-58
61. Shumaker SA, Legault C, Rapp SR, Thal L, Wallace RB, et al. 2003. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 289:2651-62
62. Stampfer MJ, Colditz GA. 1991. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev. Med. 20:47-63
63. Stefanick ML, Anderson GL, Margolis KL, Hendrix SL, Rodabough RJ, et al. 2006. Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy. JAMA 295:1647-57
64. Steinberg KK, Thacker SB, Smith SJ, Stroup DF, Zack MM, et al. 1991. A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer. JAMA 265:1985-90
65. Subar AF, Kipnis V, Troiano RP, Midthune D, Schoeller DA, et al. 2003. Using intake biomarkers to evaluate the extent of dietary misreporting in a large sample of adults: the OPEN study. Am. J. Epidemiol. 158:1-13
66. Tannenbaum A. 1942. Genesis and growth of tumors III. Effect of a high fat diet. Cancer Res. 2:468-75
67. Wactawski-Wende J, Kotchen JM, Anderson GL, Assaf AR, Brunner RL, et al. 2006. Calcium plus Vitamin D supplementation and the risk of colorectal cancer. N. Engl. J. Med. 354:684-96
68. Wassertheil-Smoller S, Hendrix SL, Limacher M, Heiss G, Kooperberg C, et al. 2003. Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial. JAMA 289:2673-84
69. Wittes J, Barrett-Connor E, Braunwald E, Chesney M, Cohen HJ, et al. 2007. Monitoring the randomized trials of the Women's Health Initiative: the experience of the Data and Safety Monitoring Board. Clin. Trials 4:218-34
70. Women's Health Initiat. Steer. Comm. 2004. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 291:1701-12
71. Women's Health Initiat. Study Group. 1998. Design of the Women's Health Initiative Clinical Trial and Observational Study. Control. Clin. Trials 19:61-109
72. World Cancer Res. Fund. 1997. Food, Nutrition, and the Prevention of Cancer: A Global Perspective. Washington, DC: Am. Inst. Cancer Res.
73. World Health Organ./Food Agric. Organ. 2003. Diet, nutrition, and the prevention of chronic diseases. WHO Tech. Rep. Ser. 916, Geneva, Switz.
74. Writ. Group Women's Health Initiat. Investig. 2002. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288:321-33